Lytix Biopharma presenting at major investor conferences in London and Stockholm in November
Oslo, 8 November 2023. Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces that Dr Øystein Rekdal, CEO, will deliver oral presentations to institutional investors in London at the LSX Inv€$tival Showcase on the 13[th ]of November, and attend the Jefferies Healthcare Conference on the 14[th ]-16[th ]November. Investors interested in meeting should get in contact through the event partnering system or through the IR team. Later in the month, on the 23[rd] of November, Dr Rekdal will give a presentation at the Redeye Life